Detailed evaluation of pyruvate dehydrogenase complex inhibition in simulated exercise conditions, Jelinek and Moxley, 2021

Andy

Retired committee member
The mammalian pyruvate dehydrogenase complex (PDC) is a mitochondrial multienzyme complex that connects glycolysis to the tricarboxylic acid cycle, by catalyzing pyruvate oxidation to produce acetyl-CoA, NADH, and CO 2. This reaction is required to aerobically utilize glucose, a preferred metabolic fuel, and is composed of three core enzymes: pyruvate dehydrogenase (E1), dihydrolipoyl transacetylase (E2), and dihydrolipoyl dehydrogenase (E3).

The pyruvate dehydrogenase specific kinase (PDK) and phosphatase (PDP) are considered the main control mechanism of mammalian PDC activity. However, PDK and PDP activity are allosterically regulated by several effectors fully overlapping PDC substrates and products. This collection of positive and negative feedback mechanisms confounds simple predictions of relative PDC flux, especially when all effectors are dynamically modulated during metabolic states that exist in physiologically realistic conditions, such as exercise.

Here we provide, to our knowledge, the first globally fitted pH-dependent kinetic model of the PDC accounting for the PDC core reaction, as it is regulated by PDK, PDP, metal binding equilibria, and numerous allosteric effectors. The model was used to compute PDH regulatory complex flux as a function of previously determined metabolic conditions used to simulate exercise and demonstrates increased flux with exercise. Our model reveals that PDC flux in physiological conditions is primarily inhibited by product inhibition (∼60%), mostly NADH inhibition (∼30 to 50%), rather than phosphorylation cycle inhibition (∼40%), but the degree to which depends on the metabolic state and PDC tissue source.
Paywall, https://www.cell.com/biophysj/pdf/S0006-3495(21)00058-8.pdf
 
Back
Top Bottom